26 Results for "

VEGF-C

" in MedChemExpress (MCE) Product Catalog:
Products (26)

26 Results for "VEGF-C" in MCE Product Catalog:

  • Recombinant Proteins Recommended:
8
8 Publications Verification
Cat. No.: HY-116624
CAS No.: 163655-37-6
Purity:  99.76%
Target:  

VEGFR Apoptosis

Research Areas:  

Cancer

MAZ51 is a selective inhibitor of VEGFR-3 (Flt-4) tyrosine kinase. MAZ51 inhibits VEGF-C-induced activation of VEGFR-3 without blocking VEGF-C-mediated stimulation of VEGFR2. MAZ51 had no effect on ligand-induced autophosphorylation of EGFR, IGF-1R and PDGFRβ. MAZ51 blocks proliferation and induces apoptosis in a wide variety of tumor cells. Antitumor activity .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-P74474
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Flt4-L; vascular endothelial growth factor C; VEGFC; VRP
Species:  
Source:  
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N2187
CAS No.: 43043-74-9
Deoxyshikonin increases the expression of VEGF-C and VEGF-A mRNA in HMVEC-dLy, promotes HIF-1α and HIF-1β subunit interaction and binds to specific DNA sequences targeted by HIF. Deoxyshikonin inhibited colorectal cancer (CRC) through the PI3K/Akt/mTOR pathway. Deoxyshikonin has proangiogenesis effect and antitumor activity. Deoxyshikonin is an antibacterial agent against methicillin-resistant S. aureus (MRSA) and S. pneumonia (MIC=17 μg/mL) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-132305
CAS No.: 2756668-73-0
Purity:  98.55%
Target:  

VEGFR

Research Areas:  

Cancer

VEGFR-3-IN-1 is a potent and selective VEGFR3 inhibitor with an IC50 of 110.4 nM. VEGFR-3-IN-1 significantly inhibits proliferation and migration of VEGF-C-induced human dermal lymphatic endothelial cells (HDLEC), MDA-MB-231, and MDA-MB-436 cells by inactivating the VEGFR3 signaling pathway, and also effectively inhibits breast cancer growth .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P7313
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuVEGF-C; Vascular endothelial growth factor C; Flt4-L; VRP
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P9920A
CAS No.: 947687-13-0

Target:  

VEGFR

Research Areas:  

Cancer

Ramucirumab (anti-VEGFR) is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab (anti-VEGFR) is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D. Ramucirumab (anti-VEGFR) is also an angiogenesis inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P990675

Target:  

VEGFR

Research Areas:  

Inflammation/Immunology

VGX-100 is a humanized antibody expressed in CHO cells, targeting VEGFC. VGX-100 is composed of huIgG1 heavy chains and huλ light chains, with a predicted molecular weight (MW) of 143.6 kDa. The isotype control for VGX-100 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-152293
CAS No.: 1412453-70-3
Target:  

VEGFR ERK

Research Areas:  

Cancer

EVT801 is an orally active and selective inhibitor of VEGFR-3 (IC50=11 nM), which has antitumor effects. EVT801 inhibits not only VEGF-C-induced human endothelial cell proliferation, but also tumor (lymphatic) angiogenesis in tumor mouse models. EVT801 can reduce tumor hypoxia, immunosuppressive cytokines (CCL4, CCL5) and myeloid derived suppressor cells (MDSC) production. EVT801 has synergistic effect with immune checkpoint therapy (ICT), which improves ICT response rate and has better inhibitory effect on cancer mouse models . EVT801 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-145633
CAS No.: 2568358-31-4
Purity:  98.52%
Synonyms: OPT 302; VGX-300

Target:  

VEGFR

Research Areas:  

Cardiovascular Disease

Sozinibercept (OPT 302; VGX-300) is a soluble form of VEGFR-3, potently inhibits the activity of VEGF-C/D, which are the proangiogenic factors, inhibiting angiogenesis and vascular leakage. Sozinibercept also inhibits diabetic retinal edema in rats .
loading...
    loading...
Cat. No.: HY-P3369
CAS No.: 2417491-82-6
Synonyms: AXT-107
Gersizangitide (AXT107) is an anti-angiogenic peptide consisting of 20 amino acids, derived from collagen IV. Gersizangitide is an inhibitor of VEGF-A and VEGF-C and an activator of Tie2. Gersizangitide can block VEGF receptor signaling, inhibit vascular leakage, neovascularization and inflammation. Gersizangitide can be used in the research of diseases related to ocular neovascularization and angiogenesis .
loading...
    loading...
Cat. No.: HY-P99830
CAS No.: 1227158-72-6
Synonyms: KH902
Conbercept (KH902) is a recombinant fusion protein composed of VEGFR-1 (second domain) and VEGFR-2 (third and fourth domains) regions fused to human IgG1 Fc. Conbercept is a VEGF inhibitor (IC50 = 8.8 pM) and is a soluble receptor decoy that blocks all isoforms of VEGF-A (Kd = 0.5 pM), VEGF-B (Kd = 8 pM), VEGF-C, and PlGF (Kd = 5 pM). Conbercept has anti-inflammatory effects, can lower the levels of VEGF, TNF-α and IL-6, and reduce the infiltration of inflammatory cells. Conbercept decreases tumor growth in several oncology studies. Conbercept can be used for various eye diseases such as polypoidal choroidal vasculopathy (PCV), diabetic macular edema (DME) and pathologic myopia choroidal neovascularization (pmCNV) .
loading...
    loading...
Cat. No.: HY-RS16674
Research Areas:  

Others

Vegfc Mouse Pre-designed siRNA Set A contains three designed siRNAs for Vegfc gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-174508
Target:  

mRNA

Research Areas:  

Cancer

Human VEGFC mRNA encodes the human vascular endothelial growth factor C (VEGFC) protein, a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. VEGFC promotes angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels.
loading...
    loading...
Cat. No.: HY-P11474
FZ1 peptide is a cyclic heptapeptide and also an integrin αvβ3 agonist. FZ1 peptide activates the FAK/PI3K-AKT/ERK pathway and upregulates VEGFC to promote angiogenesis. FZ1 peptide exhibits antibacterial activity in extracts of HA-c-FZ1 hydrogel; it inhibits LPS-induced proinflammatory cytokine secretion in RAW264.7 macrophages; it reduces H2O2-induced ROS levels; it increases the healing rate of scratch wounds. FZ1 peptide can be used in studies related to diabetic skin wounds .
loading...
    loading...
Cat. No.: HY-RS15637
Research Areas:  

Others

VEGFC Human Pre-designed siRNA Set A contains three designed siRNAs for VEGFC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P77864
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: VEGFC; VEGF-CC; VEGFc; Flt4-L; VRP;
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P77865
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: VEGFC; VEGF-CC; VEGFc; Flt4-L; VRP;
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P70501
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Vascular Endothelial Growth Factor C; VEGF-C; Flt4 Ligand; Flt4-L; Vascular Endothelial Growth Factor-Related Protein; VRP; VEGFC
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P74475
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Flt4-L; vascular endothelial growth factor C; VEGFC; VRP
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P73529
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Flt4-L; vascular endothelial growth factor C; VEGFC; VRP
Species:  
Source:  
loading...
    loading...